Printer Friendly

ELAN CONFIDANT OF SUCCESSFUL CONCLUSION TO PATENT INFRINGEMENT CASE

 ELAN CONFIDANT OF SUCCESSFUL CONCLUSION TO PATENT INFRINGEMENT CASE
 ATHLONE, Ireland, June 25 /PRNewswire/ -- Elan Corporation plc (ADS - AMEX: ELN) today announced that the U.S. District Court for the northern district of California stated in a judgment that Cygnus did not perform any infringement of Elan's patent in their activities prior to product launch.
 The court did state that certain testing of the Cygnus product would have infringed Elan's method claims but for an exemption granted in respect to clinical studies reasonably required for FDA approval.
 Accordingly, Elan remains confident that once the Cygnus product is marketed that its continuing action for infringement of Elan's claims will be successful.
 Elan Corporation plc is a leader in the specialized health care field of advanced reformulations and drug delivery, concentrating on improved drug absorption and utilization. Elan operates research and manufacturing facilities in Athlone; Gainesville, Ga.; Enschede, Netherlands; Manila, Philippines; Brea, Calif.; Cambridge, Mass.; and Mezzovico, Switzerland.
 -0- 6/25/92
 /CONTACT: Brian Crotty of Elan, 800-252-3526; or Thomas Redington, 203-222-7399 or 212-926-1733, for Elan/
 (ELN) CO: Elan Corporation plc ST: IN: MTC SU:


GK-AH -- NY070 -- 3936 06/25/92 16:19 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 25, 1992
Words:192
Previous Article:BEAR STEARNS MORTGAGE CERTIFICATES 1992-3 RATED 'AAA/AA' BY FITCH -- FITCH FINANCIAL WIRE --
Next Article:INVESTMENT COMPANY INSTITUTE REPORTS ON ASSETS OF MONEY MARKET FUNDS
Topics:


Related Articles
ELAN: COURT REFUSES TO CONTINUE RESTRAINT AGAINST MARION MERRELL DOW
ALZA, CYANAMID, ELAN AND MARION MERRELL CONCLUDE AGREEMENTS AND REACH AN OUT-OF-COURT SETTLEMENT
COURT RULES IN FAVOR OF CYGNUS MOTION FOR SUMMARY JUDGMENT; DISMISSES IMPORTANT PARTS OF PATENT INFRINGEMENT SUIT
COURT DISMISSES PFIZER SUIT AGAINST ELAN
CYGNUS REACHES SETTLEMENT WITH ELAN OVER NICOTINE PATCH SUIT
Hoechst Marion Roussel Announces Stipulation With Andrx in Patent Lawsuit Involving Cardizem(R) CD
Elan announces court decision affirming non-infringement.
Tkt and Aventis Pharma motion for judgment of non-infringement granted by United States district court.
Cambridge Antibody Technology comments on Griffiths patent.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters